Published in JAMA on July 28, 1978
Antibody capture immunoassay detection of japanese encephalitis virus immunoglobulin m and g antibodies in cerebrospinal fluid. J Clin Microbiol (1982) 3.44
Molecular diagnosis of herpes simplex virus infections in the central nervous system. J Clin Microbiol (1999) 2.21
Varicella-zoster-associated encephalitis: detection of specific antibody in cerebrospinal fluid. J Clin Microbiol (1980) 1.45
Herpes encephalitis is a disease of middle aged and elderly people: polymerase chain reaction for detection of herpes simplex virus in the CSF of 516 patients with encephalitis. The Study Group. J Neurol Neurosurg Psychiatry (1996) 1.18
Herpes simplex type 2 encephalitis concurrent with known cerebral metastases. Acta Neuropathol (1979) 1.13
Antiherpesvirus activity in human sera and urines after administration of adenine arabinoside: in vitro and in vivo synergy of adenine arabinoside and arabinosylhypoxanthine in combination. J Clin Invest (1978) 0.92
Diagnosis of herpes simplex virus encephalitis by detection of virus-specific immunoglobulins A and G in serum and cerebrospinal fluid by using an antibody-capture enzyme-linked immunosorbent assay. J Clin Microbiol (1989) 0.87
Diagnostic value of cerebrospinal fluid antibodies in herpes simplex virus encephalitis. J Neurol Neurosurg Psychiatry (1982) 0.82
Quantitative uptake studies of 131I-labeled (E)-5-(2-iodovinyl)-2'-deoxyuridine in herpes simplex virus-infected cells in vitro. Antimicrob Agents Chemother (1984) 0.78
Non-invasive method for early diagnosis of herpes simplex encephalitis. Arch Dis Child (1988) 0.75
Herpes simplex encephalitis: poor outcome despite adenine arabinoside therapy. Can Med Assoc J (1982) 0.75
Community-acquired methicillin-resistant Staphylococcus aureus endocarditis in the Detroit Medical Center. Ann Intern Med (1982) 2.94
Virus myocardiopathy. Prog Med Virol (1973) 2.73
Residual pathologic changes following murine coxsackie A and B myocarditis. Am J Pathol (1969) 2.47
Mumps arthritis: unusual presentation as adult Still's disease. Ann Intern Med (1982) 2.21
The clinical spectrum of endophthalmitis: incidence, predisposing factors, and features influencing outcome. J Infect Dis (1990) 1.84
Bacteremia in narcotic addicts at the Detroit Medical Center. II. Infectious endocarditis: a prospective comparative study. Rev Infect Dis (1986) 1.82
Current problems in the treatment of infective endocarditis due to Pseudomonas aeruginosa. Rev Infect Dis (1983) 1.80
Characteristics of pneumonias caused by Escherichia coli. N Engl J Med (1967) 1.68
Incubation of swab materials with herpes simplex virus. J Infect Dis (1980) 1.58
Coxsackievirus myocarditis--with special reference to acute and chronic effects. Prog Cardiovasc Dis (1985) 1.57
Augmentation of the virulence of murine coxsackie-virus B-3 myocardiopathy by exercise. J Exp Med (1970) 1.54
The clinical spectrum of Mycoplasma pneumoniae infections. Med Clin North Am (1978) 1.46
Editorial response: microbial persistence and idiopathic dilated cardiomyopathy. Clin Infect Dis (1999) 1.45
Idiopathic CD4+ T-lymphocytopenia--an analysis of five patients with unexplained opportunistic infections. N Engl J Med (1993) 1.38
Comparison of conventional dosing versus continuous-infusion vancomycin therapy for patients with suspected or documented gram-positive infections. Antimicrob Agents Chemother (1996) 1.29
In-vitro evaluation of cefpirome (HR 810), teicoplanin and four other antimicrobials against enterococci. J Antimicrob Chemother (1985) 1.29
Teicoplanin pharmacokinetics in intravenous drug abusers being treated for bacterial endocarditis. Antimicrob Agents Chemother (1991) 1.29
Characteristics of nonbacteremic Pseudomonas pneumonia. Ann Intern Med (1968) 1.27
Bacteroides pneumonias. Characteristics of cases with empyema. Ann Intern Med (1968) 1.26
Bacteremia in narcotic addicts at the Detroit Medical Center. I. Microbiology, epidemiology, risk factors, and empiric therapy. Rev Infect Dis (1986) 1.25
Differential sensitivity of herpes simplex virus types 1 and 2 to human interferon: antiviral effects of interferon plus 9-beta-D-arabinofuranosyladenine. J Infect Dis (1976) 1.21
Herpesvirus hominis encephalitis in Michigan. Report of thirteen cases, including six treated with idoxuridine. N Engl J Med (1970) 1.18
Pneumonias caused by gram negative bacilli. Medicine (Baltimore) (1966) 1.18
Coxsackievirus myocardiopathy. J Infect Dis (1969) 1.17
Passive hemagglutinating antibodies in cerebrospinal fluids in herpesvirus hominis encephalitis. 1. Proc Soc Exp Biol Med (1972) 1.16
Xeroradiographic, bacteriologic, and pathologic studies in experimental staphylococcus osteomyelitis. Proc Soc Exp Biol Med (1977) 1.16
Treatment of patients with pseudomonas endocarditis with high dose aminoglycoside and carbenicillin therapy. Medicine (Baltimore) (1978) 1.16
Localized mucormycosis following intramuscular corticosteroid. Case report and review of the literature. Am J Med Sci (1978) 1.16
Vancomycin Ototoxicity in patient with normal renal function. Ann Intern Med (1981) 1.16
Randomised, controlled trial of the comparative efficacy, auditory toxicity, and nephrotoxicity of tobramycin and netilmicin. Lancet (1983) 1.14
Hemophilus influenzae bronchopneumonia in adults. Arch Intern Med (1968) 1.14
Idoxuridine in herpes simplex virus (type 1) encephalitis. Experience with 29 cases in Michigan, 1966 to 1971. Ann Intern Med (1973) 1.12
An experimental approach to virus myocarditis. Prog Med Virol (1965) 1.09
The association of Streptococcus bovis fecal carriage and colon neoplasia: possible relationship with polyps and their premalignant potential. Am J Gastroenterol (1985) 1.09
A new continuing fatigue syndrome following mild viral illness. A proscription to exercise. Chest (1988) 1.08
Microbiologic assays and neurological toxicity during use of adenine arabinoside in humans. J Infect Dis (1976) 1.07
Infections due to Achromobacter xylosoxidans. Case report and review of the literature. Infection (1987) 1.06
Hallucinations in an elderly patient taking recommended doses of cyclobenzaprine. Arch Intern Med (2000) 1.05
Theophylline-induced seizures: clinical and pathophysiologic aspects. West J Med (1983) 1.05
Modified polyriboinosinic-polyribocytidylic acid complex: sustained interferonemia and its physiological associates in humans. Infect Immun (1979) 1.05
Comparison of the effects of arabinosyladenine, arabinosylhypoxanthine, and arabinosyladenine 5'-monophosphate against herpes simplex virus, varicella-zoster virus, and cytomegalovirus with their effects on cellular deoxyribonucleic acid synthesis. Antimicrob Agents Chemother (1981) 1.04
Mycotic aneurysm and endocarditis. Two uncommon complications of salmonella infection in the same patient. Am J Cardiol (1966) 1.04
The classic bacterial pneumonias. Dis Mon (1975) 1.03
Complement-requiring neutralizing antibodies in Herpesvirus hominis encephalitis. J Immunol (1970) 1.02
Enterovirus hemagglutination: inhibition by several enzymes and sugars. J Immunol (1965) 1.02
A mouse model of dilated-type cardiomyopathy due to coxsackievirus B3. J Infect Dis (1981) 1.01
Evaluation of Acinetobacter baumannii infection and colonization, and antimicrobial treatment patterns in an urban teaching hospital. Pharmacotherapy (1999) 1.00
A pharmacist-initiated program of intravenous to oral antibiotic conversion. Pharmacotherapy (1997) 1.00
Synergy of 9-beta-D-arabinofuranosyladenine and human interferon against Herpes simplex virus, type 1. J Infect Dis (1974) 1.00
Herpesvirus hominis encephalitis. Neurological manifestations and use of idoxuridine. Arch Neurol (1970) 1.00
Delayed detection of an increase in resistant Acinetobacter at a Detroit hospital. Infect Control Hosp Epidemiol (1992) 0.99
Serologic responses to herpes simplex virus in rabbits: complement-requiring neutralizing, conventional neutralizing, and passive hemagglutinating antibodies. J Infect Dis (1974) 0.99
Virus myopericarditis. Ann Intern Med (1968) 0.99
Pseudomonas cepacia peritonitis associated with contamination of automatic peritoneal dialysis machines. Ann Intern Med (1982) 0.98
Non-traumatic gram-negative bacillary meningitis in the Detroit Medical Center, 1964-1974; (with special mention of cases due to Escherichia coli). Medicine (Baltimore) (1978) 0.97
Synergy between carbenicillin and an aminoglycoside (gentamicin or tobramycin) against Pseudomonas aeruginosa isolated from patients with endocarditis and sensitivity of isolates to normal human serum. J Infect Dis (1979) 0.97
Gentamicin in treatment of primary Gram-negative pneumonias. Am J Med Sci (1970) 0.96
Comparative efficacies of imipenem-cilastatin and vancomycin in experimental aortic valve endocarditis due to methicillin resistant Staphylococcus aureus. J Antimicrob Chemother (1988) 0.96
Outcomes with daptomycin versus standard therapy for osteoarticular infections associated with Staphylococcus aureus bacteraemia. J Antimicrob Chemother (2007) 0.96
Cellular interactions of several enteroviruses and a reovirus after treatment with sodium borohydride or carbohydrases. Virology (1968) 0.96
Age-dependent pathogenicity of group B coxsackieviruses in Swiss-Webster mice: infectivity for myocardium and pancreas. J Infect Dis (1980) 0.96
Mumps arthritis: a review of the literature. Rev Infect Dis (1984) 0.94
Some previously unrecognized features of herpes simplex virus encephalitis. Neurology (1978) 0.94
Characteristics and sequelae of paregoric abuse. Ann Intern Med (1966) 0.93
Cefamandole-erythromycin-heparin peritoneal irrigation: an adjunct to the surgical treatment of diffuse bacterial peritonitis. Surgery (1983) 0.92
Antiherpesvirus activity in human sera and urines after administration of adenine arabinoside: in vitro and in vivo synergy of adenine arabinoside and arabinosylhypoxanthine in combination. J Clin Invest (1978) 0.92
Enterovirus hemagglutination: inhibition by aldoses and a possible mechanism. J Immunol (1966) 0.92
Commercial test sensitivity to cryptococcal antigen. Ann Intern Med (1977) 0.92
Agranulocytosis associated with chronic oral administration of cloxacillin for suppression of staphylococcal osteomyelitis. Am J Hematol (1982) 0.90
Granulocytopenia associated with carbenicillin. Five episodes in two patients. Am J Med (1973) 0.90
Renal and auditory toxicity of high-dose, prolonged therapy with gentamicin and tobramycin in pseudomonas endocarditis. J Infect Dis (1984) 0.90
Role of bacterial infection in exacerbation of multiple sclerosis. Am J Phys Med Rehabil (1996) 0.89
Antiviral activity of an adenosine deaminase inhibitor: decreased replication of herpes simplex virus. J Infect Dis (1975) 0.89
Pseudomonas endocarditis: hemagglutinating antibodies to Fisher-Devlin-Gnabasik immunotypes in sera. J Lab Clin Med (1974) 0.89
Citrobacter diversus at Grace Hospital, Detroit, Michigan. Am J Med Sci (1976) 0.89
Congenital infections with reovirus. J Exp Med (1966) 0.89
Immunoassay with cytomegalovirus early antigens from gene products p52 and CM2 (UL44 and UL57) detects active infection in patients with chronic fatigue syndrome. J Clin Pathol (2007) 0.89
Gram-negative pneumonia in hospitalized patients. Postgrad Med (1975) 0.89
The gram-negative bacillary pneumonias. Dis Mon (1980) 0.88
Pyrogenic reactions after inadvertent infusion of endotoxin during cardiac catheterizations. Ann Intern Med (1980) 0.87
Eczema herpeticum: presenting as hand, foot and mouth syndrome. Mich Med (1972) 0.87
Clinical characteristics and outcomes of diabetic patients with Staphylococcus aureus bacteremia and endocarditis. Eur J Clin Microbiol Infect Dis (2009) 0.86
Effect of periodate oxidation on hemagglutinating and antibody-producing capacities of certain enteroviruses and reoviruses. Proc Natl Acad Sci U S A (1966) 0.86
Coxsackievirus B4 myocarditis in mice: valvular changes in virus-infected and control animals. J Infect Dis (1978) 0.86
A mouse model of transmural myocardial necrosis due to coxsackievirus B4: observations over 12 months. Intervirology (1982) 0.86
Studies of in vitro synergy between several beta-lactam and aminoglycoside antibiotics against endocarditis strains of Pseudomonas aeruginosa. J Infect (1984) 0.86
Guide to immunization against mumps. J Infect Dis (1970) 0.86
Gram-negative bacillary pneumonia. J Infect Dis (1971) 0.86
Adenovirus pneumonia in healthy adults. Heart Lung (1987) 0.86
Gentamicin/amikacin-resistant gram-negative bacilli at Detroit General Hospital, 1975-1976. Am J Med (1977) 0.85
Ventricular aneurysms complicating coxsackievirus group B, types 1 and 4 murine myocarditis. Circulation (1979) 0.85
Epidemiologic studies on influenza in familial and general population groups, 1951-1956. V. Effectiveness of adjuvant vaccines. Am J Epidemiol (1969) 0.84
Possible pseudoresistance of Streptococcus pneumoniae to penicillin G in a patient with a mixed pneumococcus-Staphylococcus aureus pneumonia. Am J Med Sci (1984) 0.84
Interferon and neutralizing antibody in sera of exercised mice with coxsackievirus B-3 myocarditis. Proc Soc Exp Biol Med (1976) 0.83